Leadership Overview
EMS Pharma has 5 executives leading key functions including strategy, finance, and operations.
Driven by a commitment to health, EMS Pharma distributes pharmaceuticals across Brazil, upholding a legacy of quality and accessibility since its founding in 1950.
Driven by a commitment to health, EMS Pharma distributes pharmaceuticals across Brazil, upholding a legacy of quality and accessibility since its founding in 1950.
Leadership Roles at EMS Pharma
Omar Sabri - Chief Executive Officer
Omar Sabri, the Chief Executive Officer at EMS Pharma, directs the company's overall strategic vision and operational execution. Sabri guides the organization's expansion efforts within the Brazilian pharmaceutical market, ensuring alignment with the company's mission to distribute essential medicines. This leadership role involves overseeing all major business units and fostering innovation in pharmaceutical distribution channels. Omar Sabri drives the company's commitment to quality and accessibility, critical components of EMS Pharma's market presence. The Chief Executive Officer's purview extends to managing key stakeholder relationships and ensuring sustainable growth in a competitive landscape. By focusing on operational efficiencies and market penetration, Sabri solidifies EMS Pharma's position as a leading domestic pharmaceutical distributor in Brazil.
Gustavo Bizinelli - Chief Financial Officer
Gustavo Bizinelli, the Chief Financial Officer at EMS Pharma, manages all financial operations and fiscal strategy. Bizinelli oversees budgeting, financial planning, and risk management, ensuring the company's financial health and stability. This executive function is crucial for supporting EMS Pharma's distribution network across Brazil. Gustavo Bizinelli's responsibilities include optimizing financial performance, securing capital for growth initiatives, and maintaining compliance with regulatory financial standards. The Chief Financial Officer's strategic insights inform investment decisions and operational expenditures, directly impacting the company's ability to expand its pharmaceutical distribution. By meticulously managing financial resources, Bizinelli supports the long-term viability and market competitiveness of EMS Pharma.
Rex Crater - President
Rex Crater, the President at EMS Pharma, spearheads key operational initiatives and market development strategies. Crater directs the expansion of EMS Pharma's pharmaceutical distribution network throughout Brazil, focusing on enhancing logistical efficiency and product reach. This leadership position involves overseeing critical business functions that support the company's mission of providing accessible medicines. Rex Crater's strategic direction ensures that EMS Pharma maintains its competitive edge in the domestic pharmaceutical sector. The President's role encompasses driving operational excellence and fostering strong relationships with supply chain partners. By focusing on market penetration and service delivery, Crater strengthens EMS Pharma's impact in the Brazilian healthcare landscape.
Carl Meares - President
Carl Meares, the President at EMS Pharma, drives strategic growth and operational oversight for the company's pharmaceutical distribution activities. Meares focuses on enhancing the company's market presence and ensuring the efficient delivery of pharmaceuticals across Brazil. This executive role involves managing key business segments and fostering collaborations that expand EMS Pharma's reach. Carl Meares' leadership is instrumental in navigating the complexities of the pharmaceutical supply chain. The President's responsibilities include implementing innovative distribution models and ensuring adherence to quality standards. By directing operational strategies, Meares supports EMS Pharma's commitment to making essential medicines widely available.
Ken Krasko - President
Ken Krasko, the President at EMS Pharma, oversees critical aspects of the company's operational strategy and market expansion. Krasko directs initiatives aimed at strengthening EMS Pharma's position as a leading pharmaceutical distributor within Brazil. This executive function involves managing key relationships and optimizing the supply chain to ensure timely product delivery. Ken Krasko's focus is on driving efficiency and innovation in pharmaceutical distribution channels. The President's role encompasses ensuring compliance with industry regulations and enhancing the company's service offerings. By leading strategic projects, Krasko contributes significantly to EMS Pharma's mission of providing accessible healthcare solutions across the nation.
Explore Leadership Teams in Manufacturing
Bausch Health Companies Inc. operates as a global pharmaceutical and healthcare products company focused on developing, manufacturing, and marketing a broad portfolio of branded pharmaceuticals, generic medicines, over-the-counter healthcare products, and medical devices. The organization works to improve patient health outcomes by delivering therapeutic solutions across multiple medical specialties. Through its research, development, and commercial operations, the company serves healthcare providers, hospitals, pharmacies, and patients across numerous international markets. The company functions as a diversified healthcare enterprise with business segments that address several therapeutic and medical device categories. Its core focus areas include gastroenterology, hepatology, neurology, dermatology, dentistry, medical aesthetics, and ophthalmology. By maintaining a broad therapeutic portfolio, the organization supports healthcare professionals in diagnosing, managing, and treating a wide range of medical conditions that affect millions of patients globally.
Company Leadership
TU
RL
CM
GC Biopharma Corp., formerly known as Green Cross Corporation, is a South Korean biopharmaceutical company specializing in the development, manufacturing, and distribution of vaccines, plasma-derived therapies, and other pharmaceutical products. Founded in 1967 and headquartered in Yongin, South Korea, GC Biopharma has grown into one of the leading companies in the Korean pharmaceutical industry, with a strong international presence.
Company Leadership FK
SK
JP
KL
Parabolic Drugs Limited is a vertically integrated, research-based pharmaceutical manufacturer and exporter, specializing in the production of over 50 active pharmaceutical ingredients (APIs) and intermediates across various therapeutic segments. The company operates four large-scale facilities, including three state-of-the-art manufacturing plants and a custom synthesis and R&D center. With a focus on backward and forward integration, world-class infrastructure, and strong R&D capabilities, Parabolic Drugs is committed to delivering high-quality products. Their diverse product portfolio is supported by intellectual property rights, including Drug Master Files (DMFs) and patents for novel processes.
Company Leadership AN
AJ
RG
YB
Kite Pharma, founded in 2009, is a pharmaceutical company specializing in cell therapy to treat and potentially cure cancer. The company focuses on engineered T cell therapy for hematologic malignancies and is committed to making these innovative treatments accessible to eligible patients. Unlike traditional pharmaceutical manufacturing, Kite Pharma's approach involves reengineering a patient's own immune cells to fight cancer cells individually. The company operates dedicated cell therapy manufacturing facilities in California, Maryland, and the Netherlands, with corporate headquarters in Santa Monica, California. Kite Pharma continues to advance cancer immunotherapy through its specialized treatments and research.
Company Leadership NS
LM
KD
Frequently Asked Questions Regarding EMS Pharma Top Executives and Leadership Team
